Biomea Fusion, Inc. (BMEA) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $7.00K; Additional Paid in CapitalUSD $481.92M; Retained Earnings (Accumulated Deficit)USD $-469.79M; Stockholders' Equity Attributable to ParentUSD $12.14M.
- 2026-03-31: Common Stock, Value, IssuedUSD $7.00K; Additional Paid in CapitalUSD $480.18M; Retained Earnings (Accumulated Deficit)USD $-461.46M; Stockholders' Equity Attributable to ParentUSD $18.72M.
- 2025-12-31: Common Stock, Value, IssuedUSD $7.00K; Additional Paid in CapitalUSD $478.59M; Retained Earnings (Accumulated Deficit)USD $-449.05M; Stockholders' Equity Attributable to ParentUSD $29.55M.
- 2025-09-30: Common Stock, Value, IssuedUSD $6.00K; Additional Paid in CapitalUSD $469.27M; Retained Earnings (Accumulated Deficit)USD $-453.66M; Stockholders' Equity Attributable to ParentUSD $15.62M.
Biomea Fusion, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.00K | $481.92M | $-469.79M | $12.14M | (m) | 3 month · $1.59M | (m) |
| 2026-03-31 | $7.00K | $480.18M | $-461.46M | $18.72M | (m) | 3 month · $1.58M | (m) |
| 2025-12-31 | $7.00K | $478.59M | $-449.05M | $29.55M | (m) | 12 month · $9.52M | (m) |
| 2025-09-30 | $6.00K | $469.27M | $-453.66M | $15.62M | (m) | 3 month · $1.94M | (m) |
| 2025-06-30 | $6.00K | $464.76M | $-437.25M | $27.51M | (m) | 3 month · $2.57M | (m) |
| 2025-03-31 | $4.00K | $445.25M | $-416.51M | $28.74M | 3 month · $5.00K | 3 month · $3.17M | (m) |
| 2024-12-31 | $4.00K | $438.82M | $-387.25M | $51.57M | (m) | 12 month · $19.09M | (m) |
| 2024-09-30 | $4.00K | $433.92M | $-357.95M | $75.97M | (m) | 3 month · $4.74M | (m) |
| 2024-06-30 | $4.00K | $429.11M | $-325.16M | $103.95M | (m) | 3 month · $4.84M | (m) |
| 2024-03-31 | $4.00K | $423.20M | $-287.89M | $135.31M | (m) | 3 month · $5.02M | (m) |
| 2023-12-31 | $4.00K | $418.06M | $-248.82M | $169.24M | (m) | 12 month · $14.13M | (m) |
| 2023-09-30 | $4.00K | $413.55M | $-213.94M | $199.61M | (m) | 3 month · $3.60M | (m) |
| 2023-06-30 | $4.00K | $409.81M | $-185.51M | $224.31M | (m) | 3 month · $3.44M | (m) |
| 2023-03-31 | $3.00K | $243.75M | $-160.62M | $83.13M | (m) | 3 month · $3.23M | (m) |
| 2022-12-31 | $3.00K | $240.11M | $-131.57M | $108.54M | (m) | 12 month · $10.34M | $-1.00K |
| 2022-09-30 | $3.00K | $236.90M | $-106.26M | $130.63M | (m) | 3 month · $2.73M | $-13.00K |
| 2022-06-30 | $3.00K | $233.77M | $-83.37M | $150.39M | (m) | 3 month · $2.56M | $-17.00K |
| 2022-03-31 | $3.00K | $230.89M | $-66.11M | $164.76M | (m) | 3 month · $2.33M | $-23.00K |
| 2021-12-31 | $3.00K | $228.53M | $-49.74M | $178.78M | (m) | 12 month · $6.23M | $-10.00K |
| 2021-09-30 | $2.00K | $226.36M | $-35.03M | $191.33M | (m) | 3 month · $1.92M | $2.00K |
| 2021-06-30 | $2.00K | $224.44M | $-22.43M | $202.02M | (m) | 3 month · $1.46M | $2.00K |
| 2021-03-31 | $1.00K | $14.26M | $-14.03M | $221.00K | (m) | 3 month · $919.00K | $-15.00K |
| 2020-12-31 | $1.00K | $13.34M | $-8.18M | $5.17M | (m) | 12 month · $322.00K | (m) |
| 2020-09-30 | (m) | (m) | (m) | $7.70M | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | $8.83M | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | $-369.00K | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | $-21.00K | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | $-263.00K | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |